找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Quality Assurance in Dialysis; Lee W. Henderson,Richard S. Thuma Book 1999Latest edition Springer Science+Business Media Dordrecht 1999 di

[復制鏈接]
樓主: LEVEE
31#
發(fā)表于 2025-3-26 22:19:00 | 只看該作者
32#
發(fā)表于 2025-3-27 01:50:19 | 只看該作者
,Reuse of dialyzers — implications for adequacy of dialysis,ly practiced in many countries to partially defray the burgeoning cost of end-stage renal dis- ease therapy [3, 4]. Prior to 1982 (when a change in dialysis reimbursement was introduced), only 20% of units in the U.S.A. were practicing reuse [5]. Since then, the use of reprocessed dialyzers has stea
33#
發(fā)表于 2025-3-27 05:57:18 | 只看該作者
34#
發(fā)表于 2025-3-27 10:20:06 | 只看該作者
35#
發(fā)表于 2025-3-27 15:18:06 | 只看該作者
36#
發(fā)表于 2025-3-27 19:12:58 | 只看該作者
Quality Criteria for the Clinical Record, and feedback to the renal care team. Designed properly, the dialysis facility clinical record can facilitate timely and accurate communication of patient care information to the renal care team, promote quality of service provided, and contribute to both qualitative and quantitative evaluation of care.
37#
發(fā)表于 2025-3-27 22:46:19 | 只看該作者
The impact of global vigilance reporting requirements on the quality of dialysis products and servirstand product safety and performance on a world-wide basis. The resulting depth and specificity of quality system requirements have led to significant demands on both industry and governmental agencies.
38#
發(fā)表于 2025-3-28 05:02:55 | 只看該作者
Global spectrum of quality assurance in the provision of dialysis,differences between the various nations and their inhabitants. Certainly, it is important to define and understand what quality is before it can be examined which in itself creates another dilemma as quality is interpreted differently by everyone.
39#
發(fā)表于 2025-3-28 10:08:50 | 只看該作者
Clinical Quality of the Patient at Onset of Dialysis Treatment, improvements in the science and technology of renal replacement therapy, the prognosis of this patient population remains poor. Moreover, the health care cost of treating the U.S. ESRD program exceed $8 billion annually.
40#
發(fā)表于 2025-3-28 14:07:31 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 18:43
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
满洲里市| 眉山市| 遂宁市| 类乌齐县| 汉源县| 苏州市| 桦南县| 独山县| 东港市| 马鞍山市| 德保县| 耒阳市| 丹棱县| 许昌县| 凉山| 鞍山市| 额尔古纳市| 故城县| 泸定县| 余干县| 肇东市| 纳雍县| 东莞市| 江永县| 海宁市| 吉首市| 伊吾县| 蒙山县| 禄劝| 汉川市| 砀山县| 南宫市| 平乐县| 永登县| 婺源县| 荣成市| 平安县| 南涧| 武功县| 出国| 绥滨县|